• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将成本效益信息外推至当地情况。

Extrapolation of cost-effectiveness information to local settings.

作者信息

Bryan S, Brown J

机构信息

Health Economics Research Group, Brunel University, UK.

出版信息

J Health Serv Res Policy. 1998 Apr;3(2):108-12. doi: 10.1177/135581969800300209.

DOI:10.1177/135581969800300209
PMID:10180659
Abstract

Providers and purchasers of health care are increasingly looking to the results of economic evaluations for guidance when making their decisions. In this paper the authors argue that there are dangers involved in the naive and unthinking use of published cost-effectiveness information outside the setting in which the information was generated. In considering whether the results of a published study are likely to be relevant locally, decision-makers are encouraged to assess whether the values of the key parameters reported in the published study apply locally. The possible sources of variation are described: unit cost differences; differences in the prevalence, incidence or natural history of disease; and differences in the comparators. In situations where the only source of variation is that local unit costs are different, local values can be substituted in the published analysis and local cost-effectiveness results estimated. Where the other sources of variation exist, the decision-maker is required to make an assumption about the nature of the interaction between the sources of variation and the values of the cost-effectiveness parameters. Using an example, the authors argue that local threshold analysis can aid decision-making where the policy change being considered has a high probability either of increasing effectiveness or reducing costs. Without local re-analysis, there is a danger that local policy changes in line with the recommendations of published studies will promote inefficiency. Re-analysis in the local setting is, however, reliant on authors of economic evaluations being explicit about their methods and the comparators used in their analyses.

摘要

医疗保健服务提供者和购买者在做决策时越来越多地寻求经济评估结果的指导。在本文中,作者认为,在信息产生的背景之外,天真且不加思考地使用已发表的成本效益信息存在风险。在考虑已发表研究的结果是否可能在当地具有相关性时,鼓励决策者评估已发表研究中报告的关键参数值是否适用于当地。文中描述了可能的差异来源:单位成本差异;疾病患病率、发病率或自然史的差异;以及对照物的差异。在唯一的差异来源是当地单位成本不同的情况下,可以在已发表的分析中代入当地值,并估算当地的成本效益结果。在存在其他差异来源的情况下,决策者需要对差异来源与成本效益参数值之间的相互作用性质做出假设。作者通过一个例子指出,在考虑中的政策变化很可能提高效果或降低成本的情况下,当地阈值分析有助于决策。如果不进行当地重新分析,存在这样一种风险,即符合已发表研究建议的当地政策变化将导致效率低下。然而,在当地环境中进行重新分析依赖于经济评估的作者明确其方法以及分析中使用的对照物。

相似文献

1
Extrapolation of cost-effectiveness information to local settings.将成本效益信息外推至当地情况。
J Health Serv Res Policy. 1998 Apr;3(2):108-12. doi: 10.1177/135581969800300209.
2
Opportunity costs and uncertainty in the economic evaluation of health care interventions.医疗保健干预措施经济评估中的机会成本与不确定性
Health Econ. 2002 Jan;11(1):23-31. doi: 10.1002/hec.641.
3
Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force.预算影响分析——良好实践原则:ISPOR 2012 预算影响分析良好实践 II 工作组报告。
Value Health. 2014 Jan-Feb;17(1):5-14. doi: 10.1016/j.jval.2013.08.2291. Epub 2013 Dec 13.
4
Discounting in health care decision-making: time for a change?医疗保健决策中的贴现:是时候做出改变了吗?
J Public Health Med. 1992 Sep;14(3):250-6.
5
Cost-effectiveness league tables: think of the fans.成本效益排行榜:想想球迷们。
Health Policy. 1995 Mar;31(3):231-8. doi: 10.1016/0168-8510(94)00719-u.
6
Cost-effectiveness analysis and health care resource allocation: decision rules under variable returns to scale.成本效益分析与医疗保健资源分配:规模报酬可变下的决策规则
Health Econ. 2004 Jan;13(1):21-35. doi: 10.1002/hec.793.
7
Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis.预算影响分析良好实践原则:ISPOR良好研究实践特别工作组——预算影响分析报告
Value Health. 2007 Sep-Oct;10(5):336-47. doi: 10.1111/j.1524-4733.2007.00187.x.
8
Affordability and cost-effectiveness: decision-making on the cost-effectiveness plane.可承受性与成本效益:成本效益层面的决策
Health Econ. 2001 Oct;10(7):675-80. doi: 10.1002/hec.639.
9
Using cost-effectiveness/cost-benefit analysis to allocate health resources: a level playing field for prevention?利用成本效益/成本效益分析来分配卫生资源:预防的公平竞争环境?
Am J Prev Med. 1997 Jan-Feb;13(1):18-25.
10
A critical review of health-related economic evaluations in Australia: implications for health policy.对澳大利亚与健康相关的经济评估的批判性综述:对健康政策的影响。
Health Policy. 1995 Feb;31(2):111-25. doi: 10.1016/0168-8510(94)00672-5.

引用本文的文献

1
Utilities of the EQ-5D: transferable or not?EQ-5D 的效用:可转移性?
Pharmacoeconomics. 2009;27(9):767-79. doi: 10.2165/11314120-000000000-00000.
2
Economic evidence at the local level : options for making it more useful.地方层面的经济证据:使其更具实用性的选项
Pharmacoeconomics. 2007;25(12):1055-62. doi: 10.2165/00019053-200725120-00006.
3
Cost and cost-effectiveness of nationwide school-based helminth control in Uganda: intra-country variation and effects of scaling-up.乌干达全国范围内以学校为基础的蠕虫控制的成本及成本效益:国内差异与扩大规模的影响
Health Policy Plan. 2008 Jan;23(1):24-35. doi: 10.1093/heapol/czm041. Epub 2007 Nov 17.
4
Do economic evaluations have a role in decision-making in Medicine Management Committees? A qualitative study.经济评估在药品管理委员会的决策中起作用吗?一项定性研究。
Pharm World Sci. 2007 Dec;29(6):661-70. doi: 10.1007/s11096-007-9125-z. Epub 2007 Jun 14.
5
Economics methods in Cochrane systematic reviews of health promotion and public health related interventions.Cochrane系统评价中关于健康促进及公共卫生相关干预措施的经济学方法
BMC Med Res Methodol. 2006 Nov 15;6:55. doi: 10.1186/1471-2288-6-55.
6
'Lost in translation': accounting for between-country differences in the analysis of multinational cost-effectiveness data.“翻译中的迷失”:跨国成本效益数据分析中各国差异的考量
Pharmacoeconomics. 2006;24(11):1101-19. doi: 10.2165/00019053-200624110-00007.
7
A decision chart for assessing and improving the transferability of economic evaluation results between countries.一份用于评估和提高经济评估结果在不同国家之间可转移性的决策图表。
Pharmacoeconomics. 2004;22(13):857-76. doi: 10.2165/00019053-200422130-00004.
8
Developing intermediate care provided by general practitioners with a special interest: the economic perspective.由全科医生提供的具有特殊兴趣的中级护理服务的发展:经济学视角。
Br J Gen Pract. 2003 Jul;53(492):553-6.
9
Generalized cost-effectiveness analysis for national-level priority-setting in the health sector.卫生部门国家级优先事项设定的广义成本效益分析。
Cost Eff Resour Alloc. 2003 Dec 19;1(1):8. doi: 10.1186/1478-7547-1-8.
10
Design, analysis and presentation of multinational economic studies: the need for guidance.跨国经济研究的设计、分析与呈现:指导的必要性。
Pharmacoeconomics. 2002;20(2):75-90. doi: 10.2165/00019053-200220020-00001.